Amneal (NYSE: AMRX) EVP Boyer settles RSUs, withholds stock for tax

Rhea-AI Filing Summary

Amneal Pharmaceuticals, Inc. Executive Vice President Andrew S. Boyer reported multiple equity award vestings and related share transfers. On March 3, 2026, performance-based restricted stock units, including 397,554 performance-based RSUs, were certified as having met their performance threshold and vested, then settled into an equal number of Class A Common Stock shares on a one-for-one basis. Several time-based restricted stock unit grants also vested and were settled into Class A Common Stock.

To cover tax withholding obligations tied to these vestings, Boyer had blocks of Class A Common Stock withheld, including 199,175 shares at $13.31 per share and 19,136 shares at $13.30 per share, classified as tax-withholding dispositions. Following the transactions on March 4, 2026, Boyer directly held 426,072 shares of Amneal Class A Common Stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOYER ANDREW S

(Last) (First) (Middle)

C/O AMNEAL PHARMACEUTICALS, INC.

(Street)

BRIDGEWATER NJ 08807

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Amneal Pharmaceuticals, Inc. [ AMRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/03/2026		M		39,252(1)	A	(2)	191,678	D
Class A Common Stock	03/03/2026		F		19,945(3)	D	$13.31	171,733	D
Class A Common Stock	03/03/2026		M		49,694(1)	A	(2)	221,427	D
Class A Common Stock	03/03/2026		F		24,897(3)	D	$13.31	196,530	D
Class A Common Stock	03/03/2026		M		24,258(1)	A	(2)	220,788	D
Class A Common Stock	03/03/2026		F		12,154(3)	D	$13.31	208,634	D
Class A Common Stock	03/03/2026		M		397,554	A	(4)	606,188	D
Class A Common Stock	03/03/2026		F		199,175(5)	D	$13.31	407,013	D
Class A Common Stock	03/04/2026		M		38,195(1)	A	(2)	445,208	D
Class A Common Stock	03/04/2026		F		19,136(3)	D	$13.3	426,072	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	03/03/2026		M			39,252	(6)	(6)	Class A Common Stock	39,252	$0	0	D
Restricted Stock Units	(2)	03/03/2026		M			49,694	(7)	(7)	Class A Common Stock	49,694	$0	49,695	D
Restricted Stock Units	(2)	03/03/2026		M			24,258	(8)	(8)	Class A Common Stock	24,258	$0	72,774	D
Performance-Based Restricted Stock Units	(4)	03/03/2026		M			397,554	(4)	(4)	Class A Common Stock	397,554	$0	0	D
Restricted Stock Units	(2)	03/04/2026		M			38,195	(9)	(9)	Class A Common Stock	38,195	$0	76,389	D

Explanation of Responses:

1. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.

2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

3. Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

4. Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5.

5. Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units.

6. On March 4, 2022, the reporting person was granted 157,005 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

7. On March 3, 2023, the reporting person was granted 198,777 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

8. On March 3, 2025, the reporting person was granted 97,032 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

9. On March 4, 2024, the reporting person was granted 152,778 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

Remarks:

	/s/ Denis Butkovic, Attorney-in-Fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Amneal (AMRX) executive Andrew S. Boyer report in this Form 4 filing?

Andrew S. Boyer reported vesting and settlement of restricted stock units and performance-based restricted stock units into Amneal Class A Common Stock, along with share withholdings used to satisfy tax obligations related to those equity awards.

How many performance-based restricted stock units vested for AMRX executive Andrew Boyer?

Andrew Boyer had 397,554 performance-based restricted stock units certified as meeting their performance threshold. These units vested and were settled into an equal number of Amneal Class A Common Stock shares on a one-for-one basis after the three-year performance period.

Were any of Andrew Boyer’s AMRX shares sold on the open market in this Form 4?

The filing shows tax-withholding dispositions, not open-market sales. Shares of Amneal Class A Common Stock were withheld to satisfy tax obligations tied to vesting restricted stock units and performance-based awards, including 199,175 shares at $13.31 per share.

How many Amneal Class A shares does Andrew Boyer hold after these transactions?

After the reported transactions on March 4, 2026, Andrew Boyer directly held 426,072 shares of Amneal Class A Common Stock, reflecting the net effect of equity award vesting and shares withheld for tax obligations.

What triggered the vesting of Andrew Boyer’s performance-based RSUs at Amneal (AMRX)?

The performance-based restricted stock units vested after Amneal’s Class A Common Stock achieved specified average closing prices over a three-year performance period. This certification resulted in 200% of the target number of units vesting and settling into common shares.

What prices were used for Andrew Boyer’s AMRX tax-withholding share dispositions?

Tax-withholding dispositions of Amneal Class A Common Stock were reported at prices of $13.30 and $13.31 per share, including 199,175 shares at $13.31 and 19,136 shares at $13.30 used to satisfy related tax obligations.